Related Experiment Videos
Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP)
Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1979
Abstract:
The clinical features of the Verner-Morrison syndrome are surveyed. This rare clinical entity still needs to be more clearly defined. Especially in relation to the role of VIP and the clinical value of VIP measurements. A case with a good correlation between the activity of the disease and circulating VIP is presented.